Syngene International has made a strong debut on Indian bourses listing at INR295 ($4.6) and closing higher, even as the overall market declined in the country. Syngene is the research services arm of Biocon.
The Syngene stock touched a high of INR318.20 on the Bombay Stock Exchange (BSE) on Aug.11, before ending at INR310.40.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?